Jason Gross
Chief Tech/Sci/R&D Officer at HLS THERAPEUTICS INC.
Net worth: 171 465 $ as of 2024-04-29
Profile
Jason A.
Gross is currently working as the Vice President-Scientific Affairs at HLS Therapeutics, Inc. He started this position in 2014.
Previously, he worked as the Vice President-Scientific & Medical Affairs at Cipher Pharmaceuticals, Inc. from 2012 to 2013.
He also held the position of Vice President at Lumira Capital Investment Management, Inc. Additionally, he worked as the VP-Scientific & Medical Affairs at IVAX Pharmaceuticals, Inc. and as the VP-Regulatory Affairs & Quality Assurance at Drugabuse Sciences, Inc. Dr. Gross obtained a doctorate degree from the University of Arizona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HLS THERAPEUTICS, INC.
0.16% | 2024-05-12 | 49,700 ( 0.16% ) | 171 465 $ | 2024-04-29 |
Jason Gross active positions
| Companies | Position | Start |
|---|---|---|
| HLS THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2014-05-31 |
Former positions of Jason Gross
| Companies | Position | End |
|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Private Equity Investor | 2006-03-30 |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology HLS Therapeutics, Inc. provides specialty pharmaceutical products. It focuses on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company was founded by William McDowall Wells, Gregory Gubitz, Gilbert Godin and Joseph Anthony MacLean and is headquartered in Etobicoke, Canada. | Corporate Officer/Principal | - |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Chief Tech/Sci/R&D Officer | - |
| Drugabuse Sciences, Inc. | General Counsel | - |
| CIPHER PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
Training of Jason Gross
| University of Arizona | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Private companies | 4 |
|---|---|
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
| Drugabuse Sciences, Inc. | |
IVAX Pharmaceuticals, Inc.
IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Health Technology |
HLS Therapeutics, Inc. /Old/
HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology HLS Therapeutics, Inc. provides specialty pharmaceutical products. It focuses on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company was founded by William McDowall Wells, Gregory Gubitz, Gilbert Godin and Joseph Anthony MacLean and is headquartered in Etobicoke, Canada. | Health Technology |
- Stock Market
- Insiders
- Jason Gross
